| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |